Venezuela Pharmaceuticals & Healthcare Q4 2019
Our outlook for the Venezuelan pharmaceutical market remains grim, as the full-blown economic, political andhumanitarian crisis continues to deteriorate the healthcare system. Many multinational drugmakers have all but abandonedoperations in the Latin American country following huge inflation-related hits to revenue. An escalation in the US sanction regimeon Venezuela will also likely make foreign firms extremely hesitant to interact with private businesses. As such, Venezuela will remainone of the most unattractive pharmaceutical and healthcare markets globally.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook